J. Curtis Nickel, MD, FRCSC, presented “Infection and Prostate Cancer: “The Old Story”” during the 30th Annual International Prostate Cancer Update on January 23rd, 2020 in Beaver Creek, Colorado.

How to cite: Nickel, J. Curtis. “Infection and Prostate Cancer: “The Old Story”” January 23rd, 2020. Accessed Nov 2024. https://dev.grandroundsinurology.com/infection-and-prostate-cancer-the-old-story/

Infection and Prostate Cancer: “The Old Story” – Summary:

J. Curtis Nickel, MD, FRCSC, Professor of Urology and Research Chair in Urologic Pain and Inflammation at Kingston General Hospital Kingston, Ontario, Canada, discusses the relationship between the prostate microbiome and prostate cancer. He goes on to discuss the intricacies of the prostate microbiome, the pitfalls of attributing inflammation and prostatitis to prostate cancer pathogenesis, as well as the impact next-generation sequencing (NGS) has on improving the identification of the microbiome within the prostate. Finally, he summarizes the association of the prostate microbiome to prostate cancer and evaluates data from several studies that attempt to correlate these microorganisms to the initiation and subsequent promotion of prostate cancer.

About The 30th Annual International Prostate Cancer Update:

The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. Dr. Moyad delivered this educational activity during the 30th iteration of the meeting in January 2020.

For further educational activities from this conference, visit our collection page.

ABOUT THE AUTHOR

Dr. Nickel is the Canada Research Chair in Urologic Pain and Inflammation and a Professor of Urology at Queen’s University in Kingston, Ontario. He is also a staff urologist at Kingston General Hospital. Dr. Nickel’s research covers inflammatory, benign prostate, and pain diseases of the urinary tract. He has over 550 publications, is on the editorial board of eight urology journals, serves as editor of the AUA Update Series, has presented in 45 countries, and is funded by the US NIH and Canadian CIHR. He has been awarded a CIHR Tier I Canada Research Chair (until 2021), as well as an AUA Distinguished Contribution Award and SIU Academy Award. He is currently Immediate Past-President of the Canadian Urological Association.